In conclusion, our study found that AR could suppress liver cancer cells invasion and proliferation capacities via miR-122-5p/RABL6 signaling, and miR-122-5p could suppress the expression of RABL6 to influence liver cancer cells progression by directly targeting the 3’UTR of RABL6-mRNA. The gene discussed is RABL6; the disease is liver cancer.